AzTrials
AzTrials

Validation StudyNCT02532751

Effects of Body Contouring Surgery in Obese Patients

An observational study of Validation Study and Quality of Life, run by Helsinki University Central Hospital at 2 sites in Finland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is twofold; 1) to assess the psychometric properties of the Finnish version of the BODY-Q questionnaire, 2) to assess the effects of body contouring surgery using patient-reported outcome measures. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Validation Study, Quality of Life
How many people
100 participants
Where
2 sitesFinland
Study dates
Apr 2018to Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: 100 patients who underwent body contour surgery

Who may be able to join

  • Body contouring surgery due to:
  • massive weight loss B) Postbariatric weight loss
  • Patient age over 18 years

Who cannot join

  • Patient age under 18 years
  • No body contouring surgery
  • Surgical intervention performed in another hospital than Helsinki and Uusimaa Hospital District
  • No obesity

Trial locations and contacts

2 sites in 1 country.

Jussi P Repo, MD contact

+358443593100

mrjussirepo@gmail.com

Pentscho Popov, MD, PhD contact

+35894711

pentscho.popov@hus.fi

Finland2 sites
  • Jorvi Central Hospital

    Espoo, Uusimaa

    Tiina Jahkola, MD, PhD

    Pauliina Homsy, MD, PhD (Cantab)

  • Helsinki University Central Hospital

    Helsinki, Uusimaa, 00029

    Jussi P Repo, MD, +358443593100, mrjussirepo@gmail.com

    Jussi P Repo, MD

Other trials in Finland

About this study

Official title: Effects of Body Contouring Surgery in Obese Patients: a Prospective Study

The aim of this study is twofold; 1) to assess the psychometric properties of the Finnish version of the BODY-Q questionnaire, 2) to assess the effects of body contouring surgery using patient-reported outcome measures.

Read the detailed description

The BODY-Q is translated into Finnish through forward and backward translation and a committee review. The preliminary version is pilot tested with 20 participants undergoing body contouring surgery.

The study is of longitudinal design gathering data from participants undergoing body contouring surgery due to obesity. Data collection takes place in the Department of Plastic Surgery, Helsinki University Central Hospital, Helsinki, Finland. The participants fill in three patient-reported outcome measures.

The outcomes of the three patient-reported outcome measures are compared with each other and internal validity assessed. Test-retest reliability is assessed after two weeks from the first completion of the questionnaires. With validated questionnaires the effects of body contouring surgery is assessed.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Validity of the Finnish version of the BODY-Q questionnaire

    The psychometric properties of the BODY-Q patient-reported outcome measure are measured

    Measured: 6 months

  2. Health-related quality of life after body contouring surgery in obese patients

    Health-related quality of life is assessed with a questionnaire

    Measured: 0.5 to 3 years

  3. Depression after body contouring surgery in obese patients

    Depression is assessed with a questionnaire

    Measured: 0.5 to 3 years

  4. Body image after body contouring surgery in obese patients

    Body image is assessed with a questionnaire

    Measured: 0.5 to 3 years

Secondary outcomes (3)
  1. The 15-Dimensions health-related quality of life instrument

    Assessment of health-related quality of life

    Measured: 0.5 to 3 years

  2. The BODY-Q questionnaire

    Assessment of health-related quality of life and body image

    Measured: 0.5 to 3 years

  3. The Raitasalo Beck Depression Index questionnaire

    Assessment of depression

    Measured: 0.5 to 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2015 (estimated)
  2. Study startApr 2018 (estimated)
  3. Primary completionDec 2020 (estimated)
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02532751
Sponsor's protocol ID
204/13/03/02/15/1
Status last verified
Feb 2018
First submitted
17 Aug 2015
Last updated
22 Feb 2018
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Validation Study and Quality of Life, run by Helsinki University Central Hospital at 2 sites in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jussi P Repo, MD (+358443593100, mrjussirepo@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Validity of the Finnish version of the BODY-Q questionnaire (time frame: 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in